“…It was already known that these protein isoinhibitors inhibit intracellular proteinases of cysteine and serine type. We had also found that cathepsin D does not inactivate (degrade) sericystatin, whereas it does inactivate other types of intracellular inhibitors, such as the inhibitors of urokinase [17,18] and elastase [17].…”